News | July 28, 2010

St. Jude Files Patent Lawsuit Against Volcano Over FFR Wires

July 28, 2010 – This week St. Jude Medical filed a patent infringement lawsuit against Volcano Corp. over its fractional flow reserve (FFR) wires. The suit was filed in federal district court in Delaware. Volcano said the claims against it are entirely without merit.

The complaint alleges Volcano infringed on five St. Jude patents related to its PressureWire. St. Jude Medical seeks injunctive relief and monetary damages.

FFR is used to evaluate the severity of stenosis in arteries to determine if the lesions should be stented.

St. Jude Medical acquired its FFR technology with the purchase of Radi Medical Systems in December 2008. Volcano is the only other company that offers an FFR system that is cleared for use by the U.S. Food and Drug Administration (FDA).

In May, St. Jude acquired LightLab Imaging Inc., which is also engaged in litigation against Volcano and subsidiary Axsun Technologies Inc. in Suffolk County, Mass. LightLab developed an optical coherence tomography (OCT) intravascular imaging system, which received FDA clearance earlier this year. Volcano is also developing an OCT system and Axsun is a supplier for LightLab.

For more information: www.volcanocorp.com, www.sjm.com

Related Content

CathWorks Receives CPT Code for Non-invasive FFRangio Measurements During PCI
News | FFR Technologies | July 12, 2018
CathWorks announced the approval of a new Current Procedural Terminology (CPT) code 0523T for non-invasive, 3-D...
The ORBITA Trial showed FFR and iFR are good predictors of PCI outcomes. This was a 2018 PCR late-breaker.
News | FFR Technologies | May 29, 2018
May 29, 2018 — The first placebo-controlled trial that looked at how fractional flow reserve (FFR) and instantaneous
FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR
Technology | FFR Technologies | May 22, 2018
Pie Medical Imaging announced that clinical data on its CAAS vFFR (Cardiovascular Angiographic Analysis Systems for...
HeartFlow FFRct Analysis Added to ITP Payment Program in the U.K.
News | FFR Technologies | April 25, 2018
HeartFlow Inc. announced that the National Health Service (NHS) England has chosen the HeartFlow FFRct (fractional flow...
Videos | FFR Technologies | March 15, 2018
An economic analysis of the DEFINE-FLAIR study comparing FFR vs. iFR, found a cost savings of nearly $900.
iFR More Cost-Effective Than FFR in PCI Guidance
News | FFR Technologies | March 12, 2018
Philips announced health economic results from the DEFINE FLAIR clinical trial comparing cost-effectiveness between...
BlueCross BlueShield Companies in Eight States Issue Positive Medical Policies for HeartFlow FFRct Analysis
News | FFR Technologies | December 28, 2017
HeartFlow Inc. announced that Health Care Service Corp. (HCSC), which operates Blue Cross and Blue Shield plans in five...
Videos | FFR Technologies | November 15, 2017
A discussion with William Fearon, M.D.
GE Healthcare and Medis Collaborate to Expand Availability of Quantitative Flow Ratio Software
News | FFR Technologies | November 10, 2017
GE Healthcare and Dutch-based cardiovascular imaging software provider Medis announced at the 2017 Transcatheter...
FAVOR II Studies Examine Diagnostic Accuracy of Quantitative Flow Ratio, FFR-Angio.
News | FFR Technologies | November 08, 2017
Investigators in the FAVOR II China and FAVOR II Europe-Japan studies recently presented their results at the 2017...
Overlay Init